Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.
Nature Medicine|April 3, 2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trialNabil F Saba, Conor E Steuer, Asari Ekpenyong, et al.
Cancer|October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapyMehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Investigational New Drugs|February 7, 2019
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trialsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Head & Neck|April 7, 2026
Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer PatientsGeorges E Daoud, Melissa F Riedel, Martha J Ryan, et al.
Cancer Cell|July 24, 2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK ActivationLingtao Jin, Jaemoo Chun, Chaoyun Pan, et al.
Cancer|March 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)Aarti Bhatia, Zhengjia Chen, Yuji Zhang, et al.
Cancer|October 25, 2019
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trialsDylan J Martini, Meredith R Kline, Yuan Liu, et al.
The Oncologist|March 13, 2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with ImmunotherapyMehmet Asim Bilen, Dylan J Martini, Yuan Liu, et al.
JAMA Oncology|May 23, 2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled TrialNabil F Saba, Stuart J Wong, Tahseen Nasti, et al.
Pageof 8